LUBBOCK, Texas, Aug. 6, 2026 /PRNewswire/ -- The Dr. Thanapoom Boonipat Grant for the Arts announces the opening of applications for its 2027 scholarship program, providing undergraduate students with an opportunity to showcase their original creative work through…
The Alzheimer's disease market dynamics are anticipated to change due to the expected launch of emerging therapies, such as Masupirdinea (Suven Life Sciences), Trontinemabb (Roche), Buntanetap (Annovis bio), Masitinib (AB Science), Remternetug (Eli Lilly), AUVELITY (AXS-05) (Axsome Therapeutics),…
Dual designations support development of a potential first disease-modifying therapy for an ultra-rare neurometabolic disorderBOSTON, Aug. 5, 2026 /PRNewswire/ -- Galibra Neuroscience announced a significant regulatory milestone with the receipt of both Orphan Drug Designation (ODD) and Rare…
TORONTO, Aug. 5, 2026 /PRNewswire/ -- Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic therapies for heart disease, is pleased to announce that it will participate…
LOS ANGELES, Aug. 4, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Alnylam Pharmaceuticals, Inc. ("Alnylam" or "the Company") (NASDAQ: ALNY)…
NAPA, Calif., Aug. 4, 2026 /PRNewswire/ -- The Doctors Company, the nation's largest physician-owned medical malpractice insurer, today released "Dentistry Claims: August Malpractice Risk Review," the newest edition in a monthly series of specialty-focused analyses designed to support…
Research estimates improper Medicaid expansion enrollment cost federal taxpayers nearly $33 billion in 2024; findings released as Paragon President Brian Blase testifies before Senate Budget CommitteeWASHINGTON, Aug. 4, 2026 /PRNewswire/ -- Paragon Health Institute released a major new research…
SHANGHAI, Aug. 4, 2026 /PRNewswire/ -- Innogen Pharmaceuticals (HK.2591), a biopharmaceutical company dedicated to innovative drug discovery and industrialization in metabolic diseases, today announced that its Efsubaglutide alfa manufacturing facility in Suzhou has officially passed a compliance inspection…
NEWARK, Del., Aug. 3, 2026 /PRNewswire/ -- According to the latest market analysis by Future Market Insights, the global Teleradiology Market is valued at USD 10.5 billion in 2025 and is expected to reach USD 12.4 billion in 2026. The…
SAN FRANCISCO, Aug. 3, 2026 /PRNewswire/ -- AusperBio Therapeutics Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a near-commercial Biopharmaceutical company focused on developing targeted oligonucleotide therapeutics for the treatment of chronic hepatitis B (CHB) and other diseases, today announced…